Ongericimab (Anti-PCSK9)
Product Specifications
CAS Number
2145096-91-7
Synonyms
JS002
Target
PCSK9
Applications
Metabolism
Additionnal Information
Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC1024461-01 250 mg
3- (1,3-dioxolan-2-yl) -5- (trifluoromethyl) -benzoic acid
Sign In for Pricing
View Details PC1024461-02 500 mg
3- (1,3-dioxolan-2-yl) -5- (trifluoromethyl) -benzoic acid
Sign In for Pricing
View Details PC1024461-03 1 g
3- (1,3-dioxolan-2-yl) -5- (trifluoromethyl) -benzoic acid
Sign In for Pricing
View Details PC1024461-04 5 g
3- (1,3-dioxolan-2-yl) -5- (trifluoromethyl) -benzoic acid
Sign In for Pricing
View Details PC1024461-05 10 g
3- (1,3-dioxolan-2-yl) -5- (trifluoromethyl) -benzoic acid
Sign In for Pricing
View Details